Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy

Immune checkpoint blockade (ICB) therapy has revolutionized cancer treatment. However, only a fraction of patients respond to ICB therapy. Accurate prediction of patients to likely respond to ICB would maximize the efficacy of ICB therapy. The tumor microenvironment (TME) dictates tumor progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramanian, Madhav, Kabir, Ashraf Ul, Barisas, Derek, Krchma, Karen, Choi, Kyunghee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873950/
https://www.ncbi.nlm.nih.gov/pubmed/36630952
http://dx.doi.org/10.1016/j.xcrm.2022.100896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873950/
https://www.ncbi.nlm.nih.gov/pubmed/36630952
http://dx.doi.org/10.1016/j.xcrm.2022.100896

Ejemplares similares